Type 2 diabetes trials in Saudi Arabia

In Saudi Arabia 8 Also abroad 1200

8 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Where
Dammam, Jeddah, Riyadh
Age
18 years and over
People
11,800 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT07064473 · EU 2025-521188-11-00
Phase 3Taking people
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
Where
Al-Ahsa, Dammam, Jeddah, Khobar, Riyadh
Age
18 years and over
People
4,500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07667803
Phase 3Taking people
A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Who Observe Ramadan Fasting
Where
Al-Ahsa, Dammam, Jeddah, Riyadh
Age
18 years to 65 years
People
130 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07613307
Phase 3Taking people
A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes
Where
Riyadh
Age
18 years to 65 years
People
57 worldwide
Run by
Vertex Pharmaceuticals Incorporated
See details and how to joinNCT04786262 · EU 2024-513929-23-00
No phaseNot yet taking people in Saudi Arabia
Effect of Prebiotics in Saudi Adults With Type 2 Diabetes
Where
Riyadh
Age
45 years to 60 years
People
100
Run by
Princess Nourah Bint Abdulrahman University
See details and how to joinNCT07464691
No phaseTaking people
Lifestyle Management App for Adults With Diabetes Type
Where
Riyadh
Age
18 years and over
People
90
Run by
Princess Nourah Bint Abdulrahman University
See details and how to joinNCT05630508
Phase 2/3Taking people
A Study of Apabetalone in Subjects With Long -COVID
Where
Al Mubarraz
Age
18 years and over
People
200 worldwide
Run by
Resverlogix Corp
See details and how to joinNCT06590324
No phaseTaking people
Non-Alcoholic Fatty Liver Disease in a Saudi Cohort With Type 2 Diabetes Mellitus
Where
Riyadh
Age
18 years to 60 years
People
1,000
Run by
King Saud University
See details and how to joinNCT05697991